全文获取类型
收费全文 | 7696篇 |
免费 | 422篇 |
国内免费 | 46篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 174篇 |
妇产科学 | 109篇 |
基础医学 | 1120篇 |
口腔科学 | 179篇 |
临床医学 | 497篇 |
内科学 | 1803篇 |
皮肤病学 | 404篇 |
神经病学 | 435篇 |
特种医学 | 256篇 |
外科学 | 979篇 |
综合类 | 32篇 |
一般理论 | 1篇 |
预防医学 | 353篇 |
眼科学 | 160篇 |
药学 | 554篇 |
中国医学 | 19篇 |
肿瘤学 | 1048篇 |
出版年
2023年 | 31篇 |
2022年 | 35篇 |
2021年 | 192篇 |
2020年 | 110篇 |
2019年 | 111篇 |
2018年 | 188篇 |
2017年 | 157篇 |
2016年 | 192篇 |
2015年 | 186篇 |
2014年 | 213篇 |
2013年 | 293篇 |
2012年 | 449篇 |
2011年 | 493篇 |
2010年 | 303篇 |
2009年 | 267篇 |
2008年 | 470篇 |
2007年 | 490篇 |
2006年 | 459篇 |
2005年 | 458篇 |
2004年 | 451篇 |
2003年 | 409篇 |
2002年 | 392篇 |
2001年 | 172篇 |
2000年 | 154篇 |
1999年 | 171篇 |
1998年 | 98篇 |
1997年 | 98篇 |
1996年 | 67篇 |
1995年 | 55篇 |
1994年 | 46篇 |
1993年 | 44篇 |
1992年 | 86篇 |
1991年 | 64篇 |
1990年 | 71篇 |
1989年 | 77篇 |
1988年 | 68篇 |
1987年 | 61篇 |
1986年 | 58篇 |
1985年 | 61篇 |
1984年 | 56篇 |
1983年 | 36篇 |
1982年 | 19篇 |
1979年 | 26篇 |
1974年 | 13篇 |
1973年 | 16篇 |
1971年 | 26篇 |
1970年 | 24篇 |
1969年 | 16篇 |
1967年 | 19篇 |
1966年 | 20篇 |
排序方式: 共有8164条查询结果,搜索用时 296 毫秒
1.
Keiko Goto Yutaka Fujiwara Takeshi Isobe Naoko Chayahara Naomi Kiyota Toru Mukohara Yukari Tsubata Takamasa Hotta Kenji Tamura Noboru Yamamoto Hironobu Minami 《Cancer science》2019,110(6):1987-1994
Although dose reduction of S‐1 is recommended for patients with impaired renal function, dose modification for such patients has not been prospectively evaluated. The aim of the present study was to investigate the pharmacokinetic parameters of 5‐fluorouracil, 5‐chloro‐2,4 dihydroxypyridine and oteracil potassium, and to review the recommended dose modification of S‐1 in patients with renal impairment. We classified patients receiving S‐1 into 4 groups according to their renal function, as measured using the Japanese estimated glomerular filtration rate (eGFR) equation. The daily S‐1 dose was adjusted based on the patient's eGFR and body surface area. Blood samples were collected for pharmacokinetic analysis. A total of 33 patients were enrolled and classified into 4 groups as follows: 10 patients in cohort 1 (eGFR ≥ 80 mL/min/1.73 m2), 10 patients in cohort 2 (eGFR = 50‐79 mL/min/1.73 m2), 10 patients in cohort 3 (eGFR = 30‐49 mL/min/1.73 m2), and 3 patients in cohort 4 (eGFR < 30 mL/min/1.73 m2). Those in cohorts 3 and 4 treated with an adjusted dose of S‐1 showed a similar area under the curve for 5‐fluorouracil (941.9 ± 275.6 and 1043.5 ± 224.8 ng/mL, respectively) compared with cohort 2 (1034.9 ± 414.3 ng/mL). Notably, while there was a statistically significant difference between cohort 1 (689.6 ± 208.8 ng/mL) and 2 (P = 0.0474) treated with an equal dose of S‐1, there was no significant difference observed in the toxicity profiles of the cohorts. In conclusion, dose adjustment of S‐1 in patients with impaired renal function using eGFR is appropriate and safe. 相似文献
2.
3.
4.
Masaru Sasaki Tsuyoshi Takahashi Soichiro Funaki Koji Tanaka Yasuhiro Miyazaki Naoko Ose Tomoki Makino Yukinori Kurokawa Makoto Yamasaki Kiyokazu Nakajima Yasushi Shintani Masaki Mori Yuichiro Doki 《Asian journal of endoscopic surgery》2021,14(1):116-119
We report a case of a diaphragmatic hernia after a heart transplant operation. A 43-year-old woman, who underwent orthotropic heart transplantation for hypertrophic cadiomyopathy two year earlier, presented with vomiting and epigastric pain. A computed tomography scan showed that the stomach and transverse colon were dislocated in the left thoracic cavity. We diagnosed left diaphragmatic hernia incarceration and performed laparoscopic repair of the diaphragmatic hernia. A 12 × 8 cm diaphragmatic defect was found intraoperatively on the ventrolateral aspect of the left diaphragm, and the stomach with volvulus had herniated into the thorax through the defect. The hernia was considered to be iatrogenic. The diaphragmatic defect was large, and the diaphragm was thinning. We closed the defect by mesh repair. Laparoscopic mesh repair of the diaphragmatic hernia could be performed safely and with minimal invasiveness. 相似文献
5.
6.
7.
8.
Cefdinir (CFDN, FK482) was evaluated for its safety, efficacy and pharmacokinetics in 28 children. CFDN was effective in 100% of 22 evaluable cases with respiratory, middle ear, urinary or soft tissue infections. From the clinical response, adverse effects and the pharmacokinetic results, daily dose of 9-18 mg/kg, administered in 3 divided portions is suggested. Increase of dose will be associated with increase of gastrointestinal side effects. The data suggest that CFDN is safe and effective when used in children with infections caused by susceptible bacteria including Staphylococcus aureus. 相似文献
9.
Tetsuo Nagatani Megumi Miyazawa Toshiko Matsuzaki Gaijiro Iemoto Shu-taku Kim Naoko Baba Kanata Miyakawa Hideaki Miyamoto Hiroshi Nakajima Yoshio Hirai 《The Journal of dermatology》1993,20(10):623-629
A 45-year-old man was referred to our department in March of 1989. Physical examination showed erythroderma, palmo-plantar hyperkeratosis, generalized lymphadenopathy, hepatosplenomegaly, and leukemic manifestation. The lymphocyte count in the peripheral blood before treatment was 1.7 × 104 cells/mm3. Atypical lymphocytes such as flower cells and lobulated cells were seen in the peripheral blood. A sample excised from a lymph node showed immunoblastic, pleomorphic T cells by a modified classification scheme of the Working Formulation. A high level of serum LDH was detected (2.1 times the upper normal limit). Anti HTLV-1 antibody was also detected in the serum. The atypical lymphocytes were positive for CD3, CD4, CD5, CD7 and HLA-DR, and negative for CD8. Thus, the clinical, pathologic and immunologic features were those of typical acute-type ATL. The patient was treated with VEPA-M for three months starting in March of 1989. Because of poor response, the patient was then treated with MACOP-B, M-FEPA, and VEPP-B for about one year from June of 1989 and has been free of disease up to the time of writing, March of 1993. 相似文献
10.
S Nakano S Suzuki H Kinbara Y Maeda M Yanagawa K Tajima H Tochigi J Kawamura S Hounoki I Yamamoto 《Hinyokika kiyo. Acta urologica Japonica》1990,36(7):831-835
This is a case report on a patient with double cancer of kidney and urinary bladder. The patient was a 65-year-old female, and she was admitted with the chief complaint of gross hematuria and right flank pain. After careful examinations, she was diagnosed with right nonfunctioning kidney caused by invasive bladder cancer. Computerized tomography incidentally revealed a mass in the upper pole of the left kidney. Selective left renal arteriography showed stretched arteries and irregularity and tortuosity of the smaller vessels. She was diagnosed with double cancer of bladder and left kidney. Owing to the damage of the right renal function, left partial nephrectomy, total cystectomy, right nephroureterectomy and left ureterocutaneostomy were performed. According to DMSA scintigraphy measured 15 days later, the uptake value of the left kidney was 13.25%, compared to the preoperative value of 25.62%. To date, this case is 36th reported case in Japan. 相似文献